Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Enliven Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- +5 vs. Q2 2022
- Shares held
- 8.23M
- −2.41M (−22.6%) vs. Q2 2022
- Total value
- $18.8M
- +$5.66M (+43.2%) vs. Q2 2022
- New holders
- 12
- 4 more added
- Sold out
- 7
- 7 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,386,568 | $10.0M | 0.20% | 00.0% | Unchanged |
| Woodline Partners LP | 866,405 | $1.98M | 0.03% | −84,888−8.9% | Reduced |
| Rock Springs Capital Management LP | 842,402 | $1.92M | 0.05% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 329,324 | $751.0K | 0.00% | −78,196−19.2% | Reduced |
| Vanguard Group Inc | 304,155 | $693.0K | 0.00% | +38,468+14.5% | Added |
| JBF Capital, Inc. | 210,000 | $479.0K | 0.12% | +210,000 | New |
| Caption Management, LLC | 170,000 | $388.0K | 0.07% | +170,000 | New |
| Bridgeway Capital Management, LLC | 126,500 | $288.0K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 109,795 | $252.0K | 0.00% | −13,166−10.7% | Reduced |
| Geode Capital Management, LLC | 105,075 | $239.0K | 0.00% | +49,336+88.5% | Added |
| Jefferies Group LLC | 104,298 | $237.8K | 0.01% | +104,298 | New |
| Parallax Volatility Advisers, L.P. | 99,099 | $226.0K | 0.00% | +99,099 | New |
| Citadel Advisors LLC | 95,342 | $217.0K | 0.00% | +95,342 | New |
| Group One Trading, L.P. | 92,994 | $212.0K | 0.01% | +92,994 | New |
| Morgan Stanley | 61,263 | $140.0K | 0.00% | −30,831−33.5% | Reduced |
| Bank of New York Mellon Corp | 52,419 | $120.0K | 0.00% | 00.0% | Unchanged |
| Marquette Asset Management, LLC | 51,567 | $118.0K | 0.04% | −27,012−34.4% | Reduced |
| MYDA Advisors LLC | 40,000 | $91.0K | 0.05% | +40,000 | New |
| Anson Funds Management LP | 28,356 | $65.0K | 0.01% | +28,356 | New |
| Dimensional Fund Advisors LP | 28,265 | $64.0K | 0.00% | +28,265 | New |
| Tudor Investment Corp Et Al | 24,502 | $56.0K | 0.00% | −27,390−52.8% | Reduced |
| State Street Corp | 21,198 | $48.0K | 0.00% | 00.0% | Unchanged |
| Great Valley Advisor Group, Inc. | 21,011 | $48.0K | 0.00% | 00.0% | Unchanged |
| Rockefeller Capital Management L.P. | 18,000 | $41.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 15,792 | $36.0K | 0.00% | +15,792 | New |
| Northern Trust Corp | 15,314 | $35.0K | 0.00% | 00.0% | Unchanged |
| AE Wealth Management LLC | 10,000 | $23.0K | 0.00% | +10,000 | New |
| Federated Hermes, Inc. | 1,575 | $4.00K | 0.00% | −2,167−57.9% | Reduced |
| Wells Fargo & Company | 94 | $0 | 0.00% | +10+11.9% | Added |
| Royal Bank of Canada | 89 | $0 | 0.00% | +57+178.1% | Added |
| JPMorgan Chase & Co | 9 | $0 | 0.00% | +9 | New |
| NEA Management Company, LLC | 0 | $0 | 0.00% | −1,006,722−100.0% | Sold out |
| Lion Point Capital, LP | 0 | $0 | 0.00% | −834,780−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −872,581−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −182,800−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −119,137−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −98,209−100.0% | Sold out |
| Panagora Asset Management Inc | 0 | $0 | 0.00% | −11,451−100.0% | Sold out |